The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer
Authors:
- Dabei TangDTDabei Tang
- Qingyuan ZhangQZQingyuan Zhang
- Shu ZhaoSZShu Zhao
- Jincai WangJWJincai Wang
- Kangping LuKLKangping Lu
- Ying SongYSYing Song
- Ling ZhaoLZLing Zhao
- Xinmei KangXKXinmei Kang
- Jingxuan WangJWJingxuan Wang
- Shanqi XuSXShanqi Xu
- Lantian TianLTLantian Tian
- 1 July 2013
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 46 (10-11) , 926-932
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancerJournal of Translational Medicine, 2012
- Circulating microRNAs: Association with disease and potential use as biomarkersCritical Reviews in Oncology/Hematology, 2011
- Significance of Heparanase in Cancer and InflammationCancer Microenvironment, 2011
- MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting HeparanaseCancer Research, 2011
- Tumorigenic and adhesive properties of heparanaseSeminars in Cancer Biology, 2010
- Serum microRNAs as non-invasive biomarkers for cancerMolecular Cancer, 2010
- Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinomaBMC Cancer, 2009
- Heparanase Augments Epidermal Growth Factor Receptor Phosphorylation: Correlation with Head and Neck Tumor ProgressionCancer Research, 2008
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005